{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:08:08Z","timestamp":1789214888854,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.urology.2018.04.006","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T19:55:52Z","timestamp":1525290952000},"page":"183-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Intraoperative Onabotulinumtoxin-A Reduces Postoperative Narcotic and Anticholinergic Requirements After Continent Bladder Reconstruction"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2573-580X","authenticated-orcid":false,"given":"Molly E.","family":"Fuchs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Beecroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1027-2953","authenticated-orcid":false,"given":"Daryl J.","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Dajusta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina B.","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2018.04.006_bib0010","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1464-410X.2007.07205.x","article-title":"Muscarinic receptor antagonists for overactive bladder","volume":"100","author":"Abrams","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2018.04.006_bib0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0269216310363649","article-title":"The impact of opioids, anticholinergic medications and disease progression on the prescription of laxatives in hospitalized palliative care patients: a retrospective analysis","volume":"24","author":"Clark","year":"2010","journal-title":"Palliat Med"},{"key":"10.1016\/j.urology.2018.04.006_bib0020","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/pan.12420","article-title":"Strategies for preventing side effects of systemic opioid in postoperative pediatric patients","volume":"24","author":"Jitpakdee","year":"2014","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.urology.2018.04.006_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10620-010-1313-3","article-title":"Overactive bladder drugs and constipation: a meta-analysis of randomized, placebo-controlled trials","volume":"56","author":"Meek","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.urology.2018.04.006_bib0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11910-014-0463-7","article-title":"Botulinum toxin for symptomatic therapy in multiple sclerosis","volume":"14","author":"Cameron","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"suppl 3","key":"10.1016\/j.urology.2018.04.006_bib0035","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/nau.22631","article-title":"Chapter 4: guidelines for the diagnosis and treatment of overactive bladder (OAB) and neurogenic detrusor overactivity (NDO)","volume":"33","author":"Nambiar","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2018.04.006_bib0040","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jpurol.2013.09.004","article-title":"Effect of onabotulinumtoxinA treatment on symptoms and urodynamic findings in pediatric neurogenic bladder","volume":"10","author":"Kask","year":"2014","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.urology.2018.04.006_bib0045","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpurol.2009.01.005","article-title":"Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"5","author":"Game","year":"2009","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.urology.2018.04.006_bib0050","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.jpedsurg.2014.04.004","article-title":"Botulinum toxin injections in the management of non-neurogenic overactive bladders in children","volume":"49","author":"Leon","year":"2014","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.urology.2018.04.006_bib0055","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jcrc.2016.07.011","article-title":"Results of implementing a pain management algorithm in intensive care unit patients: the impact on pain assessment, length of stay, and duration of ventilation","volume":"36","author":"Olsen","year":"2016","journal-title":"J Crit Care"},{"key":"10.1016\/j.urology.2018.04.006_bib0060","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s11605-015-2877-1","article-title":"Postoperative ileus\u2013more than just prolonged length of stay?","volume":"19","author":"Tevis","year":"2015","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.urology.2018.04.006_bib0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1440-1754.2005.00537.x","article-title":"Management of post-operative bladder spasm","volume":"41","author":"Chiang","year":"2005","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.urology.2018.04.006_bib0070","first-page":"217","article-title":"Factors that influence the urodynamic results of botulinum toxin in the treatment of neurogenic hyperactivity","volume":"39","author":"Gutierrez-Martin","year":"2015","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.urology.2018.04.006_bib0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","article-title":"OnabotulinumtoxinA 100\u2009U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial","volume":"64","author":"Chapple","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2018.04.006_bib0080","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-5347(06)00301-6","article-title":"The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor","volume":"176","author":"Hoebeke","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.04.006_bib0085","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00192-012-2015-5","article-title":"Botulinum neurotoxin type A injection of the pelvic floor muscle in pain due to spasticity: a review of the current literature","volume":"24","author":"Bhide","year":"2013","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.urology.2018.04.006_bib0090","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.juro.2017.02.021","article-title":"A prospective, multicenter, double-blind, randomized trial of bladder instillation of liposome formulation OnabotulinumtoxinA for interstitial cystitis\/bladder pain syndrome","volume":"198","author":"Chuang","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.04.006_bib0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1479-828X.2004.00163.x","article-title":"Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles","volume":"44","author":"Jarvis","year":"2004","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.urology.2018.04.006_bib0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/toxins8040088","article-title":"Use of botulinum toxin A in the treatment of lower urinary tract disorders: a review of the literature","volume":"8","author":"Moore","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.urology.2018.04.006_bib0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.acuro.2017.02.005","article-title":"Efficacy of botulinum toxin A for the treatment of bladder pain syndrome: a systematic review","volume":"42","author":"Ochoa Vargas","year":"2017","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.urology.2018.04.006_bib0110","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.12659\/MSM.897350","article-title":"Intravesical botulinum toxin A injections for bladder pain syndrome\/interstitial cystitis: a systematic review and meta-analysis of controlled studies","volume":"22","author":"Wang","year":"2016","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.urology.2018.04.006_bib0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/15360288.2016.1231742","article-title":"Analgesic effect of botulinum toxin A in myofascial pain syndrome patients previously treated with local infiltration of anesthetic and steroids","volume":"30","author":"Cartagena-Sevilla","year":"2016","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.urology.2018.04.006_bib0120","first-page":"406","article-title":"Color Doppler ultrasound-guided botulinum toxin type A injection combined with an ankle foot brace for treating lower limb spasticity after a stroke","volume":"19","author":"Ding","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.urology.2018.04.006_bib0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-0036-1571953","article-title":"Botulinum toxin treatment of neuropathic pain","volume":"36","author":"Mittal","year":"2016","journal-title":"Semin Neurol"},{"key":"10.1016\/j.urology.2018.04.006_bib0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s10194-016-0621-1","article-title":"The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache","volume":"17","author":"Pihut","year":"2016","journal-title":"J Headache Pain"},{"key":"10.1016\/j.urology.2018.04.006_bib0135","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/1049909117716460","article-title":"Subcutaneous botulinum toxin injection for post-thoracotomy pain syndrome in palliative care: a case report","volume":"35","author":"Rashid","year":"2017","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.urology.2018.04.006_bib0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1533-2500.2008.00202.x","article-title":"Evidence for the use of botulinum toxin in the chronic pain setting\u2013a review of the literature","volume":"8","author":"Jeynes","year":"2008","journal-title":"Pain Pract"},{"issue":"suppl 2","key":"10.1016\/j.urology.2018.04.006_bib0145","first-page":"20","article-title":"Managing anticholinergic side effects","volume":"6","author":"Lieberman","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.urology.2018.04.006_bib0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1520-6777(1999)18:3<223::AID-NAU9>3.0.CO;2-6","article-title":"Pharmacodynamics of anticholinergic agents measured by ambulatory urodynamic monitoring: a study of methodology","volume":"18","author":"Rosario","year":"1999","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2018.04.006_bib0155","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1208872","article-title":"Anticholinergic therapy vs. onabotulinumtoxinA for urgency urinary incontinence","volume":"367","author":"Visco","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429518303248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429518303248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T07:50:46Z","timestamp":1533109846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429518303248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":30,"alternative-id":["S0090429518303248"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2018.04.006","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraoperative Onabotulinumtoxin-A Reduces Postoperative Narcotic and Anticholinergic Requirements After Continent Bladder Reconstruction","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2018.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}